Adverse events induced by immune checkpoint inhibitors is a research paper published in Current Opinion in Immunology (2021). On theSindex it has a DataRank of 0. It has been cited 69 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIDDK NIH HHS
Grant: P30 DK045735
NCI NIH HHS
Grant: P50 CA121974
NCI NIH HHS
Grant: R01 CA227473
NIDDK NIH HHS
Grant: R01 DK120362
NCATS NIH HHS
Grant: UL1 TR001863
NCI NIH HHS
Grant: R01 CA216846
NIDDK NIH HHS
Grant: R43 DK116577
NIDDK NIH HHS
Grant: R01 DK057846
NIAID NIH HHS
Grant: R21 AI135562
National Institutes of Health
Grant: 1R01DK120362-01
Autoimmunity to Protein Modifications in Checkpoint Inhibitor Induced and Spontaneous T1D
National Institutes of Health
Grant: 1R43DK116577-01
Novel diagnostics for autoimmunity from checkpoint inhibitor immune therapy
National Institutes of Health
Grant: 3R01CA227473-02S1
(8) Mechanisms of autoimmune endocrine diseases in patients receiving checkpoint inhibitors
National Institutes of Health
Grant: 5R21AI135562-02
Mechanisms of Autoimmune Diabetes in Patients Treated with Immune checkpoint Inhibitors
National Institutes of Health
Grant: 2P50CA121974-06A1
The RAC1 Pathway as aTarget for Melanoma Therapy
Juvenile Diabetes Research Foundation
National Institutes of Health
FWCI
3.65
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals